0
0
Read Time:4 Minute, 6 Second
The Europe Cancer Diagnostics Market was valued at $7.94 billion in 2023. This market is expected to reach $12.21 billion by 2031, from an estimated $8.34 billion in 2024, at a CAGR of 5.6% during the forecast period 2024-2031.
Cancer diagnostics involves a variety of in vitro diagnostics and imaging tests used to detect cancers such as breast, lung, prostate, and colorectal cancers, among others. These tests assist in identifying signs of cancer, guiding treatment decisions, assessing the likelihood of recurrence, monitoring the effectiveness of treatments, and determining the type and stage of the disease. This report assesses the market for cancer diagnostic products, including kits, reagents, imaging devices, and in vitro diagnostic (IVD) instruments.
The Europe cancer diagnostics market’s growth is fueled by the rising incidence of cancer, initiatives promoting early diagnosis, growing awareness, increased funding and investments in cancer research, and technological advancements. Furthermore, initiatives supporting precision diagnostics are expected to present significant growth opportunities for companies operating in the Europe cancer diagnostics market.
Top 10 Companies in the Europe Cancer Diagnostics Market:
Thermo Fisher Scientific Inc. (U.S.)
Founded in 1956 and headquartered in Massachusetts, U.S., Thermo Fisher Scientific operates in the cancer diagnostics market through its Life Sciences Solutions and Specialty Diagnostics segments. The company provides reagents, instruments, and consumables for cancer diagnostics, catering to various industries including pharmaceuticals, biotechnology, clinical diagnostic labs, and research institutions. The company has a broad geographical presence with offices and production sites in the U.S., Europe, Asia, and beyond.
Hoffmann-La Roche Ltd (Switzerland)
Established in 1896 and headquartered in Basel, Switzerland, Roche operates in the cancer diagnostics market through its Diagnostics division. The company offers a wide range of diagnostic products including kits, reagents, and analyzers. Roche has a significant global presence with manufacturing and R&D facilities in key markets across North America, Europe, and Asia.
QIAGEN N.V. (Netherlands)
Founded in 1984 and based in Venlo, Netherlands, QIAGEN develops instruments and consumables for molecular diagnostics, including cancer diagnostics. The company operates through its Molecular Diagnostics segment and serves a broad customer base globally, with operations in more than 60 countries and production sites in the U.S., Europe, and Asia.
Download Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5787
Abbott Laboratories (U.S.)
Headquartered in Illinois, U.S., and founded in 1900, Abbott Laboratories operates in cancer diagnostics through its Core Laboratory Diagnostics and Molecular Diagnostics segments. The company offers diagnostic tests and kits globally, with an extensive presence across North America, Europe, Latin America, and Asia-Pacific, supported by a wide distribution network and manufacturing facilities.
Illumina, Inc. (U.S.)
Incorporated in 1998 and based in California, U.S., Illumina provides genomic sequencing and genetic analysis tools, with a focus on cancer diagnostics through its Core Illumina and GRAIL segments. Illumina operates globally, offering cancer diagnostics products and services to various healthcare institutions and research centers, with manufacturing and R&D sites across Europe, the U.S., and Asia.
Canon Medical Systems Corporation (Japan)
Founded in 1930, Canon Medical Systems, headquartered in Tochigi, Japan, operates in the cancer diagnostics market through its Medical Business Unit, providing imaging systems for cancer diagnosis. The company has a global presence with manufacturing and R&D facilities in Europe, Asia, and the Americas.
Siemens Healthineers AG (Germany)
Established in 1847 and headquartered in Erlangen, Germany, Siemens Healthineers is a leader in healthcare technology, offering diagnostic imaging systems, scanners, and cancer tests. Siemens operates globally with a strong presence in Europe, the Middle East, Africa, and the U.S., with production and R&D facilities in key regions.
GE HealthCare Technologies Inc. (U.S.)
Founded in 2023 after its spin-off from General Electric, GE HealthCare, based in Illinois, U.S., provides diagnostic imaging and ultrasound solutions for cancer diagnostics. The company has a significant presence in over 160 countries, supported by manufacturing and R&D facilities across the U.S., Europe, and Asia.
Koninklijke Philips N.V. (Netherlands)
Founded in 1891 and headquartered in Amsterdam, Netherlands, Philips offers diagnostic imaging systems and cancer diagnostic software through its Diagnosis & Treatment segment. Philips has a strong presence in North America, Europe, and Asia, with R&D and manufacturing facilities worldwide.
FUJIFILM Holdings Corporation (Japan)
Headquartered in Tokyo, Japan, FUJIFILM was founded in 1934 and operates in the cancer diagnostics market through its Medical Systems segment. The company maintains a global presence with manufacturing sites in the U.S., Europe, and Asia.
Buy Now: https://www.meticulousresearch.com/Checkout/57354505
Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
